The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

But that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ... Moderna and Fortune 500 competitor Pfizer’s messenger RNA COVID vaccines were the first of their kind to be ...

Messenger RNA (mRNA) vaccine platforms may offer a promising alternative to traditional vaccine methods to face H5N1 threats.

H5N1 has been the dominant grouping of strains fueling this past year's outbreaks in the U.S., with different variants of that virus spreading in wild birds, poultry flocks, dairy cattle ...

The team found that animals that had the virus inoculated directly into their lungs became severely ill, whereas animals that ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company ... also known as LUNAR-H5N1, for active immunization to prevent ...

Pasteurization at 63°C and 72°C effectively inactivates influenza A viruses in milk, ensuring its safety for human ...

Is it seasonal flu or bird flu? CDC prompts hospitals to fast-track subtype testing of sick patients to tell the difference.

SAN DIEGO, January 10, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development ...